Differences in hydrophobic properties for human alpha 2-macroglobulin and pregnancy zone protein as studied by affinity phase partitioning. 1989

G Birkenmeier, and L Carlsson-Bostedt, and V Shanbhag, and T Kriegel, and G Kopperschläger, and L Sottrup-Jensen, and T Stigbrand
Institute of Biochemistry, Karl-Marx-University, Leipzig.

Human alpha 2-macroglobulin and pregnancy zone protein are related with regard to primary structure, physicochemical properties, and quarternary structure. Both proteins undergo conformational changes when they form complexes with proteinases or react with primary amines. The surface properties of the native, chymotrypsin-treated and methylamine-treated forms of alpha 2-macroglobulin and pregnancy zone protein were studied by partitioning in aqueous two-phase systems composed of 7.5% dextran T70 and 5% poly(ethylene glycol) 8000. All proteins and their derivatives had a high potential for hydrophobic interaction as analyzed in terms of affinity for poly(ethylene glycol) esters of fatty acids included in the phase systems. Treatment of alpha 2-macroglobulin with methylamine or chymotrypsin increased the surface hydrophobicity significantly compared to that of the native protein. No difference in hydrophobic interaction was found for native and methylamine-treated pregnancy zone protein, but the chymotrypsin-treated protein showed a marked increase in binding to the hydrophobic ligand. The changes in surface hydrophobicity parallel changes in receptor binding properties of the derivatized forms of alpha 2-macroglobulin and could be a signal for binding to cell-surface receptors, followed by internalization.

UI MeSH Term Description Entries
D008744 Methylamines Derivatives of methylamine (the structural formula CH3NH2).
D010169 Palmitic Acids A group of 16-carbon fatty acids that contain no double bonds. Acids, Palmitic
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D011257 Pregnancy Proteins Proteins produced by organs of the mother or the PLACENTA during PREGNANCY. These proteins may be pregnancy-specific (present only during pregnancy) or pregnancy-associated (present during pregnancy or under other conditions such as hormone therapy or certain malignancies.) Placental Proteins,Proteins, Placental,Proteins, Pregnancy
D002498 Centrifugation Process of using a rotating machine to generate centrifugal force to separate substances of different densities, remove moisture, or simulate gravitational effects. It employs a large motor-driven apparatus with a long arm, at the end of which human and animal subjects, biological specimens, or equipment can be revolved and rotated at various speeds to study gravitational effects. (From Websters, 10th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D002918 Chymotrypsin A serine endopeptidase secreted by the pancreas as its zymogen, CHYMOTRYPSINOGEN and carried in the pancreatic juice to the duodenum where it is activated by TRYPSIN. It selectively cleaves aromatic amino acids on the carboxyl side. Alpha-Chymotrypsin Choay,Alphacutanée,Avazyme
D003911 Dextrans A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes. Dextran,Dextran 40,Dextran 40000,Dextran 70,Dextran 75,Dextran 80,Dextran B-1355,Dextran B-1355-S,Dextran B1355,Dextran B512,Dextran Derivatives,Dextran M 70,Dextran T 70,Dextran T-40,Dextran T-500,Hemodex,Hyskon,Infukoll,Macrodex,Polyglucin,Promit,Rheodextran,Rheoisodex,Rheomacrodex,Rheopolyglucin,Rondex,Saviosol,Dextran B 1355,Dextran B 1355 S,Dextran T 40,Dextran T 500
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000511 alpha-Macroglobulins Glycoproteins with a molecular weight of approximately 620,000 to 680,000. Precipitation by electrophoresis is in the alpha region. They include alpha 1-macroglobulins and alpha 2-macroglobulins. These proteins exhibit trypsin-, chymotrypsin-, thrombin-, and plasmin-binding activity and function as hormonal transporters. Slow alpha 2-Macroglobulins,alpha 2-Acute Phase Globulins,alpha-Macrofetoproteins,45S RNP,Acute-Phase alpha 1-Protein,Slow alpha 2-Globulin,alpha 1-Acute Phase Globulin,alpha 1-Acute Phase Protein,alpha 1-Macroglobulin,alpha 2-Acute Phase Globulin,alpha-Macrofetoprotein,Acute Phase alpha 1 Protein,RNP, 45S,Slow alpha 2 Globulin,Slow alpha 2 Macroglobulins,alpha 1 Acute Phase Globulin,alpha 1 Acute Phase Protein,alpha 1 Macroglobulin,alpha 1-Protein, Acute-Phase,alpha 2 Acute Phase Globulin,alpha 2 Acute Phase Globulins,alpha 2-Globulin, Slow,alpha 2-Macroglobulins, Slow,alpha Macrofetoprotein,alpha Macrofetoproteins,alpha Macroglobulins

Related Publications

G Birkenmeier, and L Carlsson-Bostedt, and V Shanbhag, and T Kriegel, and G Kopperschläger, and L Sottrup-Jensen, and T Stigbrand
July 1993, Biochimica et biophysica acta,
G Birkenmeier, and L Carlsson-Bostedt, and V Shanbhag, and T Kriegel, and G Kopperschläger, and L Sottrup-Jensen, and T Stigbrand
May 1996, Journal of chromatography. B, Biomedical applications,
G Birkenmeier, and L Carlsson-Bostedt, and V Shanbhag, and T Kriegel, and G Kopperschläger, and L Sottrup-Jensen, and T Stigbrand
December 1992, European journal of biochemistry,
G Birkenmeier, and L Carlsson-Bostedt, and V Shanbhag, and T Kriegel, and G Kopperschläger, and L Sottrup-Jensen, and T Stigbrand
December 1985, The Journal of biological chemistry,
G Birkenmeier, and L Carlsson-Bostedt, and V Shanbhag, and T Kriegel, and G Kopperschläger, and L Sottrup-Jensen, and T Stigbrand
April 1988, European journal of clinical investigation,
G Birkenmeier, and L Carlsson-Bostedt, and V Shanbhag, and T Kriegel, and G Kopperschläger, and L Sottrup-Jensen, and T Stigbrand
April 1997, Protein expression and purification,
G Birkenmeier, and L Carlsson-Bostedt, and V Shanbhag, and T Kriegel, and G Kopperschläger, and L Sottrup-Jensen, and T Stigbrand
January 1988, Placenta,
G Birkenmeier, and L Carlsson-Bostedt, and V Shanbhag, and T Kriegel, and G Kopperschläger, and L Sottrup-Jensen, and T Stigbrand
May 1990, The Journal of biological chemistry,
G Birkenmeier, and L Carlsson-Bostedt, and V Shanbhag, and T Kriegel, and G Kopperschläger, and L Sottrup-Jensen, and T Stigbrand
October 1986, Biochimica et biophysica acta,
G Birkenmeier, and L Carlsson-Bostedt, and V Shanbhag, and T Kriegel, and G Kopperschläger, and L Sottrup-Jensen, and T Stigbrand
December 1986, The Journal of biological chemistry,
Copied contents to your clipboard!